Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo

Journal of Surgical Research

Volumn 69, Issue 2, 1997, Pages 367-371

  Zervos, Emmanuel E ^a   Norman, James G ^a   Gower, William R ^b   Franz, Michael G ^a   Rosemurgy, Alexander S ^a,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c TAMPA GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; MATRIX METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER GROWTH; CANCER MORTALITY; CANCER SURVIVAL; CARCINOGENESIS; CELL VIABILITY; CONFERENCE PAPER; DOSE RESPONSE; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS CANCER; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0031148314     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5086     Document Type: Conference Paper

References (35)

1. 1. Matrisian, L. M. The matrix-degrading metalloproteinases. Bioessays 14: 455, 1992.
2. 2. Agren, M. S., Taplin, C. J., Woessner, J. F., Eaglstein, W. H., and Mertz, P. M. Collagenase activity during wound healing. J. Invest Dermatol. 98: 621, 1992.
3. 3. Reponen, P., Sahlberg, C., Huhtala, P., Hurskainen, T., Thesleff, I., and Tryggvason, K. Molecular cloning of murine 72-kD type IV collagenase and its expression during mouse development. J. Biol. Chem. 267: 7856, 1992.
4. 4. Mignatti, P., and Rifkin, D. B. Biology and biochemistry of proteinases in tumor invasion. Phys. Rev. 73: 161, 1993.
5. 5. Matrisian, L. M. Matrix metalloproteinase gene expression. Ann. N.Y. Acad. Sci. 54: 42, 1994.
6. 6. Mauch, C., Krieg, T., and Bauer, E. A. Role of the extracellular matrix in the degradation of connective tissue. Arch. Dermatol. Res. 287: 107, 1994.
7. 7. Brown, P. D. Matrix metalloproteinase inhibitors: a novel class of anticancer agents. Adv. Enzyme Regul. 35: 293, 1995.
8. 8. Freije, M. M., Diez-Itza, I., Balbin, M., Sanchez, L. M., Blasco, R., Tolovia, J., and Lopez Otin, C. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem. 269: 16766, 1994.
9. 9. Woessner, J. F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5: 2145, 1991.
10. 10. Chenard, M. P., Rio, M. C., Chambon, P., Bellocq, J. P., and Basset, P. Stromelysin-3 gene expression in human cancer: An overview. Inv. Met. 14: 269, 1994-95.
11. 11. Levy, J. T., Cioce, V., Sobel, M. E., Garbisa, S., Grigioni, W. F., Liotta, L. A., and Stetler-Stevenson, W. G. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res. 51: 439, 1991.
12. 12. Koshiba, T., Wada, M., Fujimot, K., Lee, J. U., Kato, M., Doi, R., Shimada, Y., Hosotani, R., Arii, S., and Imamura, M. Activation of MMP-2 and MMP-9 in human pancreatic cancer tissues and human pancreatic cancer cell lines. Gastroenterology 110: A545, 1996.
13. 13. Liabakk, N. B., Talbot, I., Smith, R. A., Wilkinson, K., and Balkwill, F. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res. 56: 190, 1996.
14. 14. Tryggvason, K., Hoyhtya, M., and Pyke, C. Type IV collagenases in invasive tumors [Review]. Breast Cancer Res. Treat. 24: 209, 1993.
15. 15. Waxman, J. The architecture of cancer: The tissue metalloproteinases and their inhibitors [Review]. BMJ 305: 1306, 1992.
16. 16. van der Stappen, J. W., Hendriks, T., and Wobbes, T. Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors. Int. J. Cancer 45: 1071, 1990.
17. 17. Davies, B., Miles, D. W., Happerfield, M. L. C., Naylor, M. S., Bobrow, L. G., Rubens, R. D., and Balkwill, F. R. Activity of type IV collagenases in benign and malignant breast disease. Br. J. Cancer 67: 1126, 1993.
18. 18. Stetler-Stevenson, W. G., Liotta, L. A., and Brown, P. D. The role of metalloproteinases in breast cancer. In: R. B. Dickson and M. E. Lippman (Eds.), Genes, Oncogenes and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer. Boston: Kluwer Academic 1991. P. 21.
19. 19. Chirivi, R. G., Garofalo, A., Crimmin, M. J., Bawden, L. J., Stoppacciaro, A., Brown, P. D., and Giavazzi, R. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int. J. Cancer 58: 460, 1994.
20. 20. Alvarez, O. A., Carmichael, D. F., and DeClerck, Y. A. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J. Natl. Cancer Inst. 82: 589, 1990.
21. 21. DeClerck, Y. A., Perez, N., Shimada, H., Boone, T. C., Langley, K. E., and Taylor, S. M. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res. 52: 701, 1992.
22. 22. Matrisian, L. M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6: 121, 1990.
23. 23. Stetler-Stevenson, W. G., Krutzsch, H. C., and Liotta, L. A. Tissue inhibition of metalloproteinase (TIMP-2): A new member of the metalloproteinase inhibitor family. J. Biol. Chem. 264: 17374, 1989.
24. 24. Poulsom, R., Pignatelli, M., Stetler-Stevenson, W. G., Liotta, L. A., Wright, P. A., and Jeffrey, R. E. Stromal expression of 72 kDa type IV collagenase and TIMP-2 mRNAs in colorectal neoplasia. Am. J. Pathol. 141: 389, 1992.
25. 25. Basset, P., Bellocq, J. P., Wolf, C., Stoll, I., Hutin, P., and Limacher, J. M. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699, 1990.
26. 26. Biswas, C. Tumour cell stimulation of collagenase production by fibroblasts. Biochem. Biophys. Res. Commun. 109: 1026, 1982.
27. 27. Biswas, C., Zhang, Y., DeCastro, R., Guo, H., Nakamura, T., Kataoka, H., and Nabeshima, K. The human tumor cell derived collagenase stimulatory factor is a member of the immunoglobulin superfamily. Cancer Res. 55: 434, 1995.
28. 28. Ray, J. M., and Stetler-Stevenson, W. G. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur. Resp. J. 7: 2062, 1994.
29. 29. Eccles, S. A., Box, G. M., Court, W. J., Bone, E. A., Thomas, W., and Brown, P. D. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor Batimastat (BB-94). Cancer Res. 56: 2815, 1996.
30. 30. Watson, S. A., Morris, T. M., Robinson, G., Crimmin, M. J., Brown, P. D., and Hardcastle, J. D. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res. 55: 3629, 1995.
31. 31. Davies, B., Brown, P. D., East, N., Crimmin, M. J., and Balkwill, F. R. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res. 53: 2087, 1993.
32. 32. Wang, X., Brown, P. D., Crimmin, M. J., and Hoffman, R. M. Matrix metalloproteinase inhibitor BB-94 (Batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res. 54: 4726, 1994.
33. 33. Taraboletti, G., Garofalo, A., Belotti, D., Drudis, T., Borsotti, P., Scanzani, E., Brown, P. D., and Giavazzi, R. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J. Natl. Cancer Inst. 87: 293, 1995.
34. 34. Gower, W. R., Risch, R. M., Godellas, C. M., Fabri, P. J. HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line. In Vitro Cell Dev. Biol. 30A: 151, 1994.
35. 35. Franz, M. G., Zervos, E. E., Norman, J. M., Gower, W. R., and Rosemurgy, A. S. Matrix metalloproteinase blockade decreases mortality in an orthotopic model of human pancreatic cancer. Gastroenterology 115: A1386, 1996.